[Coxibs in treatment and prevention of cancer].
Kliinisteoreettinen laitos, Haartman-instituutti ja HUSLAB, Molekyyl- ja syöpäbiologian tutkimusohjelma, Helsingin yliopisto.
Mira
M
Heinonen
Ari
A
Ristimäki
D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000453:epidemiology; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D005387:Finland; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy* / Q000517:prevention & control*; D018570:Risk Assessment; D016896:Treatment Outcome
D052246:Cyclooxygenase 2 Inhibitors